METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine
Financing Co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund
The Series D round was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund. The new capital will be used to accelerate METiS' core strategic initiatives, including automation upgrades to its proprietary platform, in-house pipeline development, expansion of global partnerships, and recruitment of world-class talent.
Left: Dr. Chris LAI, Co-founder and CEO of METiS Technologies; Right: Mr. REN Peng, Chairman and General Manager, Shunxi Management Co., Ltd., a General Partner of the Beijing Medical and Health Industry Investment Fund
The Beijing Medical and Health Industry Investment Fund (Limited Partnership) is one of eight major industrial funds established with support from the Beijing Municipal Government. It focuses on innovative pharmaceuticals, advanced medical devices, and emerging technologies such as cell and gene therapy (CGT) and digital health. The fund plays a key role in accelerating the city's biotech innovation ecosystem.
Mr. REN Peng, Chairman and General Manager of Shunxi Management Co.,Ltd. commented: "Healthcare is a cornerstone of Beijing's innovation-driven strategy and a vital engine of emerging productivity. With the launch of the city's AI+Healthcare Innovation Action Plan, Beijing is strategically integrating AI with life sciences to lead the next phase of high-quality growth. Our RMB 20 billion fund reflects our commitment to advancing innovation in CGT. METiS fills a critical gap in advanced formulation and delivery systems, and we believe their technology will set new standards in AI-powered nanodelivery."
Mr. LI Ming, Chairman of Beijing Daxing District Investment Group Co., Ltd., added:
"Daxing District is committed to making biopharma a core pillar of its economic growth strategy. The launch of the OpenCGT platform marks a major milestone that will accelerate the commercialization of cutting-edge technologies, while attracting top global talent, capital, and innovation to Daxing - enhancing our competitiveness in CGT on the world stage."
Mr. HUANG Hantao, Deputy General Manager of CICC Capital, noted:
"We are grateful for the strong support from Beijing's leadership, Shunxi Management, and Daxing District across policy, capital, talent, and infrastructure. METiS has made tremendous progress over the past two years. As a long-term investor, CICC Capital will continue to support the company in R&D collaborations with our portfolio companies, clinical development, talent acquisition, and capital markets—empowering the next wave of breakthroughs in AI-enabled drug delivery."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Upstart returns to profitability in second quarter
Online lending platform Upstart Holdings became profitable again due to higher loan origination volumes. At the same time, the company has been investing in AI and expanding its consumer credit products. Upstart, an online lending platform that serves over 3 million borrowers, reached $5.6 million in net income this quarter, a 110% improvement from the $54.5 million loss reported this time last year. It's the first time the company has reported positive income since 2022. The lender also reported $257.3 million in revenue, a 101.6% increase from the prior year. "In addition to achieving triple-digit revenue growth, we reached GAAP profitability a quarter sooner than expected," Upstart CEO Dave Girouard said in the company earnings call. Similarly, diluted earnings per share hit $0.05, a 108% increase from the -$0.62 EPS reported in the second quarter of 2024. Driving the strong earnings report was the $2.8 billion of loan originations Upstart brought in, the lender's highest origination volume for a single quarter in three years. Paul Gu, Upstart co-founder and chief technology officer, emphasized the online lender's investment in AI this year and championed it as a factor in the company's growth. "We made strong progress in Q2 generalizing our AI technology across product verticals," Gu said in the earnings call. "Even with accelerating growth in new products, our share of fully automated loans actually kept up this quarter." About 92% of the company's loans are currently fully automated with no human intervention, according to a company earnings presentation. In Upstart's first investor day held in May 2025, which it called "AI Day," the company emphasized to its investors various plans to incorporate AI into employee workflow and consumer products. "One of our key priorities in 2025 is to 10x our leadership in AI," Gu said in the earnings call. "We continue to have a robust pipeline of modeling wins, and I'm incredibly proud of the team and what we've been able to accomplish so far with that." A Jeffries analyst report said that the quarter "showed good patterns on volumes with a rising conversion rate driving $2.8 billion of loan volume, ahead of consensus but modestly short of the 'whisper #' of $3.1 billion." A "whisper number" is an unofficial earnings prediction that can circulate among Wall Street brokers and investors separately from official consensus estimates for a publicly traded company. Upstart increased its revenue outlook for the full fiscal year from $1.01 billion to $1.055 billion, and its net income guidance from a general "positive" prediction to a specific number outlook of $35 million. The lender is also taking a conservative stance on the impacts of macroeconomic conditions on the latter half of the year and "roughly expects the status quo," according to chief financial officer Sanjay Datta. Analysts on the call pushed against this stance with several questions about the lower-than-expected jobs report released last week and the potential of future interest rate cuts, even as Federal Reserve chair Jerome Powell is currently holding interest rates steady. "We plan for no real cuts in interest rates in the market," Datta said in response to an analyst question. "There's a lot of speculation around what that might look like for the rest of the year, but we certainly don't bank on anything in that regard." Upstart is also expecting a resilient labor market, according to Datta. "Notwithstanding the noise of the last week or so, we think the labor market continues to be in relatively good shape in terms of how many open jobs there are out there versus how many people are seeking jobs," he said. "That's the totality of the macro assumptions that go into our planning." Jeffries analysts noted that Upstart's third-quarter outlook changes were set above what they had expected. "FY25 guidance was [also] adjusted moderately up, which we believe may fall short of expectations considering momentum," the Jeffries report said. Shares in Upstart fell by 19% in trading on Wednesday. A Citizens analyst report on Upstart's earnings said that the firm would "remain neutral on the stock, as we believe that the valuation already captures a significant degree of the expectations for recovering volumes and margins; the near-record-high conversion rate within a more competitive lending landscape raises the credit risk profile; and we would like greater visibility into stable and permanent funding sources for new products." Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
Trump's Asia tariffs takes a massive hit on Bitcoin miners
Trump's Asia tariffs takes a massive hit on Bitcoin miners originally appeared on TheStreet. As per the latest report by The Block, President Donald Trump's latest order on global tariffs seems to be becoming a pain in the neck for the Bitcoin mining community in the U.S. As the 90-day tariff pause deadline neared, Trump announced a slew of new global tariff rates on July 31. Among the worst-hit are the key centers of mining rig manufacturing in Southeast Asia. For those unfamiliar, crypto mining is the process of using high-tech hardware to validate and secure transactions on a blockchain network. Ethan Vera, the COO of a Bitcoin mining technology and services company, Luxor Technology, shared a document with The Block as per which the latest directive imposes 21.6% tariffs, including a 19% "reciprocal tariff," on imports of application-specific integrated circuits (ASICs) from Indonesia, Malaysia, and Thailand beginning Aug. are chips that are designed to execute a specific task extremely efficiently such as crypto mining, as opposed to general-purpose processors like central processing units (CPUs) or graphics processing units (GPUs). As per the report, U.S. tariffs on imports from China, a major hub of mining rig manufacturing, stand at a staggering 57.6%, which includes a 10% baseline reciprocal tariff and an additional country‑specific tariff of 20%. Anyway, the tariff pause deadline between the two countries is set to expire on Aug. 12, and there has been no breakthrough so far. While still lower than earlier rates, the current tariffs are significantly higher than the 2.6% tariffs on ASICs imported from the Southeast Asian countries before Trump's second term. However, Chinese machines even earlier used to face an additional 25% ad valorem said, "At 21.6% tariffs, the U.S. is now one of the least competitive jurisdictions to bring machines in, and miners are looking at Canada and other markets to expand too." Opportunity for domestic manufacturers However, the new trade conditions could also lead to a rise in the prices of U.S.-based used ASIC machines in the face of high tariffs on imported rigs, he explained. Though Luxor is excited about the production of mining rigs in the U.S., it warned fully onshoring the manufacturing could take years because most of the raw materials are still imported from Asia. The mining company expected the Trump administration to exempt the mining equipment from tariff hikes in order to encourage the domestic crypto industry. Trump's Asia tariffs takes a massive hit on Bitcoin miners first appeared on TheStreet on Aug 6, 2025 This story was originally reported by TheStreet on Aug 6, 2025, where it first appeared.
Yahoo
3 minutes ago
- Yahoo
What to know about chikungunya virus in China as US issues travel alert
The U.S. Centers for Disease Control and Prevention has issued a travel warning following an outbreak of a mosquito-borne illness called chikungunya in China. The CDC's warning centers on Guangdong Province, where the outbreak has exceeded 7,000 confirmed cases since June 2025, according to Chinese health officials. The outbreak in Guangdong Province has been linked to monsoon flooding, which created ideal breeding conditions for mosquitoes, which spread the virus that causes chikungunya. In the new travel warning, the CDC emphasized that vaccination is available and recommended for travelers. Dr. Todd Ellerin, chief of infectious disease at South Shore Health in Massachusetts, told ABC News that travelers to the region "should absolutely take precautions" against the illness. "Wear long sleeves and pants, use insect repellent with DEET, and use mosquito netting for babies too young for repellent," said Ellerin, who is not affiliated with the CDC. Here is what to know about the illness. How common is chikungunya? Chikungunya is not a new infection. It has been around since the 1950s, with outbreaks more commonly seen in tropical areas in recent decades. Globally, there have been about 240,000 infections since the start of 2025, according to the European Centre for Disease Prevention and Control. Chikungunya is not common in the United States. The CDC says there have not been any reported locally acquired cases since 2019. What are the symptoms of chikungunya? According to the CDC, common symptoms of the virus include sudden-onset high fever, severe joint pain (especially in the hands, wrists, ankles, and feet), muscle pain, headache, fatigue and skin rash. Georgia woman describes crippling pain of chikungunya virus Most people recover without medical intervention within seven to 10 days, but in some cases, symptoms can persist for weeks or months. What is the incubation period for chikungunya? Chikungunya typically has an incubation period of less than one week, according to Ellerin. "If it's been more than a week since you left a high-risk area, you're likely in the clear," he said. How is chikungunya treated? There is no specific antiviral treatment for chikungunya. Instead, care focuses on relieving symptoms while the body recovers. The CDC recommends rest, fluids, and medications like acetaminophen for pain and fever. NSAIDs may be used once dengue, another mosquito-borne disease, has been ruled out. Deaths from chikungunya are rare, according to the CDC. Is there a vaccine for chikungunya? There are two vaccines available in the U.S. that begin offering protection within about two weeks of a single dose. Cases of mosquito-borne viruses on the rise The CDC recommends vaccination for travelers visiting areas with active outbreaks, people spending extend time abroad -- typically six months or longer -- and laboratory workers who handle the virus. What contributes to the spread of chikungunya? Climate change is a major driver of chikungunya's global spread. "Warmer temperatures and increased rainfall are helping Aedes mosquitoes expand into new regions," Dr. Krutika Kuppalli of the division of infectious diseases at the University of Texas Southwestern Medical Center told ABC News. Veer Patel, M.D., is an emergency medicine doctor at Maimonides Medical Center and a member of the ABC News Medical Unit. Solve the daily Crossword
